Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02768597 · ClinicalTrials.gov registry record · NA
Comparing The Outcome of Large-Diameter vs Small-Diameter Glenospheres in Primary Reverse Shoulder Arthroplasty
A NA study of Glenohumeral Joint Degeneration, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 113
- Enrollment target
- 1
- Study location
NCT02768597: Completed NA study of Glenohumeral Joint Degeneration, sponsored by Mayo Clinic.
NCT02768597 is a NA study of Glenohumeral Joint Degeneration that has completed, run by Mayo Clinic. The registered enrollment target is 113 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02768597, a NA study of Glenohumeral Joint Degeneration, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 113 participants
- Enrollment target
- 1
- Study location
Study Summary
The study will compare the outcome of primary reverse shoulder arthroplasty using the Stryker ReUnion System with implantation of either a large (40 mm) or a small (36 mm) glenosphere with either a +2 mm or a +6 mm offset.
Primary Outcome
Degrees of movement the participant is able to independently lift arm upward to the ceiling, while keeping elbow straight. Normal movement for forward elevation is 180 degrees.
Conditions Studied
Interventions
- DEVICE ReUnion System with a Large-Diameter Glenosphere +2 mm offset
- DEVICE ReUnion System with a Small-Diameter Glenosphere +2 mm offset
- DEVICE ReUnion System with a Large-Diameter Glenosphere +6 mm offset
- DEVICE ReUnion System with a Small-Diameter Glenosphere +6 mm offset
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 113 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-12-15 |
| Phase | NA |
What the finished NCT02768597 record still lists
NCT02768597 is an interventional study that assigns participants to a tested intervention. The registered 113 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Glenohumeral Joint Degeneration appearing as the primary indexed condition, and to 4 interventions - of which ReUnion System with a Large-Diameter Glenosphere +2 mm offset is the first listed.
NCT02768597 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT02768597 about?
NCT02768597 is a clinical study titled "Comparing The Outcome of Large-Diameter vs Small-Diameter Glenospheres in Primary Reverse Shoulder Arthroplasty". The study will compare the outcome of primary reverse shoulder arthroplasty using the Stryker ReUnion System with implantation of either a large (40 mm) or a small (36 mm) glenosphere with either a +2 mm or a +6 mm offset.
What is the current status of trial NCT02768597?
This trial is currently completed. It is a NA study. The enrollment target is 113 participants. The study started on 2016-04. Estimated completion is 2022-12-15.
What conditions does trial NCT02768597 study?
This clinical trial studies the following conditions: Glenohumeral Joint Degeneration.
What interventions are being tested in trial NCT02768597?
The interventions under investigation include: ReUnion System with a Large-Diameter Glenosphere +2 mm offset (DEVICE), ReUnion System with a Small-Diameter Glenosphere +2 mm offset (DEVICE), ReUnion System with a Large-Diameter Glenosphere +6 mm offset (DEVICE), ReUnion System with a Small-Diameter Glenosphere +6 mm offset (DEVICE).
Who is sponsoring clinical trial NCT02768597?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02768597 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02768597's enrollment target sits among peer trials
113 813th of 2000 higher than 1,188 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00748254 · 113 participants
Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis
- NCT04753190 · 113 participants · NA
Light Timing Study
- NCT05799248 · 113 participants · Phase 3
Role of rhPSMA-7.3 PET/CT Imaging in Men With High-Risk Prostate Cancer Following Conventional Imaging and Associated Changes in Medical Management
- NCT07216105 · 113 participants · Phase 1
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia